BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 29, 2018
View Archived Issues
Mutations mediate mantle cell lymphoma resistance
Read More
Rocket reports preclinical data on gene therapy RP-A501 for Danon disease
Read More
Fratricide-resistant, allo-tolerant "off-the-shelf" CAR-T cells for T-cell malignancies
Read More
Noncanonical activity of nuclear LDHA induced by ROS leads to HPV-induced cervical carcinogenesis
Read More
Novel LpxC inhibitors identified against Gram-negative bacteria by computational scaffold-hopping
Read More
Protagonist Therapeutics to begin clinical development of PN-10943 for IBD
Read More
Novus initiates phase I trial of OP-0201 for otitis media
Read More
Wayne State University, University of Zurich divulge apramycin derivatives
Read More
Wockhardt describes new antibacterials
Read More
Jivi approved in Europe for hemophilia A
Read More
Androgen receptor eliminators patented by Spg Therapeutics
Read More
Anti-inflammatory compositions presented by House Wellness Foods, House Foods Group
Read More
GlaxoSmithKline discovers sodium channel protein type 9 subunit alpha blockers
Read More
Blaze Bioscience initiates pivotal phase II/III study for of BLZ-100 and the Canvas Imaging System
Read More
Phase II trial opens in Congo to investigate multiple investigational Ebola therapies
Read More
FDA approves rituximab biosimilar Truxima to treat NHL
Read More
MedImmune presents new antibody-drug conjugates for cancer
Read More
New phase IIb trial investigates efficacy of male contraceptive gel
Read More
Xospata approved in U.S. for relapsed or refractory AML with FLT3 mutation
Read More
FDA approves Firdapse to treat Lambert-Eaton myasthenic syndrome
Read More
European Commission approves label extension for Kalydeco
Read More
EC grants approval to Delstrigo and Pifeltro for HIV-1 infection
Read More
European Commission approves Gilenya for children and adolescents with relapsing-remitting MS
Read More
Preclinical evaluation of next-generation retroviral vector with membrane-anchored IL-12
Read More
M-7824 demonstrates manageable safety and encouraging efficacy in rGBM
Read More
HMGA2 as potential new target for therapeutic strategies in medulloblastoma
Read More
Repurposing glioma exomes as novel strategy for multiantigenic antiglioma vaccination
Read More
Using cell free DNA from CSF provides less invasive technique to evaluate IDH1 mutation in glioma
Read More
